Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Idera Pharmaceuticals, Inc.

TRADE

NASDAQ: IDRAHealthcare / Biotechnology / USA
9.11-0.42-4.41%Vol 599 6611Y Perf -49.61%
Sep 25th, 2018 16:00
BID8.96 ASK9.99
Open9.50 Previous Close9.53
Pre-Market- After-Trading9.11
 - -%  - -%
Target Price
19.20 
Analyst Rating
Strong Buy 1.00
Potencial %
110.76 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
★★★+     56.09
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
 —    -
Market Cap (mil)248 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
22.02 
Earnings Date
5th Nov 2018

Today's Price Range

8.8810.10

 

52wk Range

5.2022.96

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Month
-0.65%
3 Months
606.20%
6 Months
348.77%
1 Year
-49.61%
3 Years
156.62%
5 Years
411.80%

Quotes

Name / TickerPriceChg.Chg.%
IDRA9.11-0.4200-4.41
AAPL222.191.40000.63
GOOG1 184.6511.28000.96
MSFT114.45-0.2200-0.19
XOM86.50-0.1000-0.12
WFC54.23-0.0300-0.06
JNJ138.64-1.8300-1.30
FB164.91-0.5000-0.30
GE11.27-0.4700-4.00
JPM116.39-0.3300-0.28
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 6.70
Current Ratio 7.00
Long Term Debt to Total Capital 0.00
Total Debt to Equity 0.00
Interest Coverage -2 048.40
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-8 682.10
EBITDA Margin-8 589.50
Pre-tax Profit Margin-23 753.10
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 2.70
PS Ratios 304.13
Price to Cash Flow 6.00
Price to Free Cash Flow -4.40
Cash Flow Per Share -2.23
Price to Tangible Book2.70
Book Value per Share3.13
Enterprise Value (in ths.)135 573
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-68.00
ROE last 12 Months -81.15
Return on Assets (5Y Avg) -46.51
ROA last 12 Months -70.98
Return on Capital (5Y Avg) -105.22
ROC last 12 Months -82.92
Return on invested Capital Q -17.72
Return on invested Capital Y-62.88
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)755
Revenue per Share 0.03
Revenue Growth 3 Years 83.77
Revenue Growth 5 Years 124.71
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.80-0.5926.25
Q01 2018-0.72-0.80-11.11
Q04 2017-0.64-0.640.00
Q03 2017-0.96-0.8016.67
Q02 2017-0.88-1.12-27.27
Q01 2017-0.80-0.800.00
Q04 2016-0.110.01109.09
Q03 2016-0.11-0.109.09
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.5630.00Positive
12/2018 QR-0.6422.89Positive
12/2018 FY-2.5816.77Positive
12/2019 FY-2.5625.58Positive
Next Report Date5th Nov 2018
Estimated EPS Next Report-0.56
Estimates Count4
EPS Growth Next 5 Years %-
Volume Overview
Volume599 661
Shares Outstanding (in ths.)27 170
Trades Count1 847
Dollar Volume5 396 535
Avg. Volume310 286
Avg. Weekly Volume438 037
Avg. Monthly Volume387 604
Avg. Quarterly Volume499 597

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

57%43%

Bearish Bullish

63%38%

Bearish Bullish

50%50%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
5 (100.00 %)
5 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x